Today's Veterinary Nurse

SEP-OCT 2017

Practical, peer reviewed, state-of-the-art companion animal nursing and technical educational articles with CE. Promotes better health for animals and career growth and development for veterinary technicians and veterinary assistants.

Issue link:

Contents of this Issue


Page 38 of 67

RECOMBITEK ® Lyme - the only vaccine with OspA in a nonadjuvanted formula Dogs take enough risks on their own. Why add unnecessary proteins to the list? Give dogs all the Lyme protection they need and none of the antigens they don't. It only takes a single protein, OspA, to block the transmission of Borrelia burgdorferi in the United States. 1,2,3 ®RECOMBITEK is a registered trademark of Merial. ©2017 Merial, Inc., Duluth, GA. All rights reserved. REC16NALYMEAD2 (09/17). 1 Straubinger RK, Chang YF, Jacobson RH, Appel MJ. Sera from OspA-vaccinated dogs, but not those from tick-infected dogs, inhibit in vitro growth of Borrelia burgdorferi. J Clin Microbiol. 1995;33(10):2745-2751. 2 Rice Conlon JA, Mather TN, Tanner P, Gallo G, Jacobson RH. Efficacy of a nonadjuvanted, outer surface protein A, recombinant vaccine in dogs after challenge by ticks naturally infected with Borrelia burgdorferi. Vet Ther. 2000;1(2):96-107. 3 Probert WS, Crawford M, Cadiz RB, LeFebvre RB. Immunization with outer surface protein (Osp) A, but not OspC, provides cross-protection of mice challenged with North American isolates of Borrelia burgdorferi. J Infect Dis. 1997;175(2):400-405. Merial is now part of Boehringer Ingelheim.

Articles in this issue

Links on this page

Archives of this issue

view archives of Today's Veterinary Nurse - SEP-OCT 2017